| Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck JS Cooper, TF Pajak, AA Forastiere, J Jacobs, BH Campbell, SB Saxman, ... New England Journal of Medicine 350 (19), 1937-1944, 2004 | 3421 | 2004 |
| Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ... Journal of clinical oncology 31 (32), 4085, 2013 | 1038 | 2013 |
| Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma JC Buckner, EG Shaw, SL Pugh, A Chakravarti, MR Gilbert, GR Barger, ... New England Journal of Medicine 374 (14), 1344-1355, 2016 | 993 | 2016 |
| Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10 LM DeAngelis, W Seiferheld, SC Schold, B Fisher, CJ Schultz Journal of Clinical Oncology 20 (24), 4643-4648, 2002 | 792 | 2002 |
| A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis RM Auchter, JP Lamond, E Alexander III, JM Buatti, R Chappell, ... International Journal of Radiation Oncology* Biology* Physics 35 (1), 27-35, 1996 | 693 | 1996 |
| Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with … L Souhami, W Seiferheld, D Brachman, EB Podgorsak, M Werner-Wasik, ... International Journal of Radiation Oncology* Biology* Physics 60 (3), 853-860, 2004 | 668 | 2004 |
| Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model LE Abrey, L Ben-Porat, KS Panageas, J Yahalom, B Berkey, W Curran, ... Journal of Clinical Oncology 24 (36), 5711-5715, 2006 | 631 | 2006 |
| Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head … JS Cooper, Q Zhang, TF Pajak, AA Forastiere, J Jacobs, SB Saxman, ... International Journal of Radiation Oncology* Biology* Physics 84 (5), 1198-1205, 2012 | 557 | 2012 |
| Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases MP Mehta, P Rodrigus, CHJ Terhaard, A Rao, J Suh, W Roa, L Souhami, ... Journal of Clinical Oncology 21 (13), 2529-2536, 2003 | 541 | 2003 |
| Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck SA Spencer, J Harris, RH Wheeler, M Machtay, C Schultz, W Spanos, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2008 | 359 | 2008 |
| Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group … C Schultz, C Scott, W Sherman, B Donahue, J Fields, K Murray, B Fisher, ... Journal of Clinical Oncology 14 (2), 556-564, 1996 | 317 | 1996 |
| Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol 90-05 E Shaw, C Scott, L Souhami, R Dinapoli, JP Bahary, R Kline, M Wharam, ... International Journal of Radiation Oncology* Biology* Physics 34 (3), 647-654, 1996 | 302 | 1996 |
| RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck SA Spencer, J Harris, RH Wheeler, M Machtay, C Schultz, W Spanos, ... International Journal of Radiation Oncology* Biology* Physics 51 (5), 1299-1304, 2001 | 230 | 2001 |
| Imaging of osteoid osteoma with dynamic gadolinium-enhanced MR imaging PT Liu, FS Chivers, CC Roberts, CJ Schultz, CP Beauchamp Radiology 227 (3), 691-700, 2003 | 205 | 2003 |
| Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma D Wang, CJ Schultz, PA Jursinic, M Bialkowski, XR Zhu, WD Brown, ... International Journal of Radiation Oncology* Biology* Physics 65 (1), 143-151, 2006 | 194 | 2006 |
| Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging … MP Mehta, WR Shapiro, MJ Glantz, RA Patchell, MA Weitzner, CA Meyers, ... Journal of clinical oncology 20 (16), 3445-3453, 2002 | 168 | 2002 |
| The transformation of radiation oncology using real-time magnetic resonance guidance: A review WA Hall, ES Paulson, UA van der Heide, CD Fuller, BW Raaymakers, ... European Journal of Cancer 122, 42-52, 2019 | 164 | 2019 |
| RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients A Chakravarti, M Wang, HI Robins, T Lautenschlaeger, WJ Curran, ... International Journal of Radiation Oncology* Biology* Physics 85 (5), 1206-1211, 2013 | 163 | 2013 |
| Association of MGMT promoter methylation status with survival outcomes in patients with high-risk glioma treated with radiotherapy and temozolomide: an analysis from the NRG … EH Bell, P Zhang, BJ Fisher, DR Macdonald, JP McElroy, GJ Lesser, ... JAMA oncology 4 (10), 1405-1409, 2018 | 157 | 2018 |
| RTOG 0525: A randomized phase III trial comparing standard adjuvant temozolomide (TMZ) with a dose-dense (dd) schedule in newly diagnosed glioblastoma (GBM). MR Gilbert, M Wang, KD Aldape, R Stupp, M Hegi, KA Jaeckle, ... Journal of Clinical Oncology 29 (15_suppl), 2006-2006, 2011 | 156 | 2011 |
